The Latest Cardiac and Vascular News
Supporting recently approved First-in-Human clinical trial at Keio University, accelerating company-sponsored clinical trials, and building a strong foundation for further growth TOKYO–(BUSINESS WIRE)–Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocyte spheroids for the treatment of heart failure (HF), today announced that Mutsuki Takano has been appointed as Chief […]
Press release Malmö, Sweden September 11, 2020 Acarix announce final outcome in oversubscribed rights issue Acarix AB (“Acarix” or the “Company”) has completed the new share issue of a maximum of 86,156,738 shares with preferential rights for the Company’s existing shareholders, which was resolved by the extra general meeting on […]
Advancing the CARENET-III study of CGuard System for Stroke Prevention in the United States TEL AVIV, Israel, Sept. 10, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced […]
Noted Tampa Bay Cardiologist, Dr. Tamboli, Joins a new Practice BRANDON, Fla., Sept. 10, 2020 Heart Vascular and Vein of Tampa Bay proudly announces that Dr. Hoshedar Tamboli will be joining the practice, starting Aug. 31, 2020. Dr. Tamboli has been in the practice of interventional and consultative cardiology in Tampa for 28 years. Recently, he was awarded “Top Cardiologist 2020” […]
LONG BEACH, Calif., Sept. 9, 2020 /PRNewswire/ — The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is expanding its leadership team with accomplished Southern California cardiologist, David Shavelle, M.D., being named medical director of adult cardiology. Dr. Shavelle is bringing his extensive leadership experience in cardiology to this new role that will provide leadership and […]
New initiative will identify gaps in care, spur quality improvement in treating vulnerable patients WASHINGTON, Sept. 10, 2020 /PRNewswire/ — The American College of Cardiology, in partnership with Novo Nordisk Inc., is launching Transforming Cardiovascular Risk in Diabetes (TRANSFORM CVRiD), a new, two-year health care quality initiative to promote cardiovascular risk reduction and […]
SEATTLE, Sept. 8, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading developer and provider of remote ambulatory cardiac monitoring and digital health solutions, announced today the appointment of Kevin Hykes as President and Chief Executive Officer, effective August 31, 2020. Hykes will also become a member of BardyDx’s Board of Directors. With over 28 years of experience in the […]
Company to accelerate development of advanced approaches for management of heart failure CAMPBELL, Calif., Sept. 8, 2020 /PRNewswire/ — Adona Medical, a Shifamed portfolio company, announced today the closing of a $22M Series A financing, which will be used to advance product development, support pre-clinical testing, and expand the team as the company furthers its […]
TEL AVIV, Israel, Sept. 8, 2020 /PRNewswire/ — MedHub Ltd, a medical technology company specializing in the development and commercialization of AI powered technologies that aid in the diagnosis of cardiac disease, announced today the appointment of Prof. Rafael Beyar as the Chairman of the company’s Board of Directors. As MedHub continues to execute on its go-to-market […]
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the company, with a term beginning effective September 1, 2020. Douglass Given, M.D., Ph.D., Chairman of the Board of Arrowhead, said, “Oye […]
